Experimental Extensively Hydrolyzed Formula

Experimental Extensively Hydrolyzed Formula is an investigational infant formula specifically developed for infants and children diagnosed with IgE-mediated cow's milk allergy (CMA). This formula undergoes extensive hydrolysis, a process that breaks down cow's milk proteins into smaller, less allergenic peptides. Its primary purpose, as evaluated in clinical trials, is to determine its hypoallergenicity, assess its safety, support healthy growth, and potentially aid in the development of tolerance to cow's milk protein in allergic individuals. It is being developed by companies such as Abbott Nutrition and Perrigo Nutritionals.